These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37775443)

  • 1. Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol.
    Bertolini A; Bloks VW; Wilmink M; Bos E; van de Peppel IP; Eilers R; Prins S; Thomas R; de Bruin A; Verkade H; Jonker JW
    J Cyst Fibros; 2024 May; 23(3):461-473. PubMed ID: 37775443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
    Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    De Lisle RC; Roach E; Jansson K
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis.
    Wouthuyzen-Bakker M; Bijvelds MJ; de Jonge HR; De Lisle RC; Burgerhof JG; Verkade HJ
    Pediatr Res; 2012 Jan; 71(1):4-12. PubMed ID: 22289844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laxative treatment with polyethylene glycol decreases microbial primary bile salt dehydroxylation and lipid metabolism in the intestine of rats.
    van der Wulp MY; Derrien M; Stellaard F; Wolters H; Kleerebezem M; Dekker J; Rings EH; Groen AK; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G474-82. PubMed ID: 23868407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
    Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
    Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse.
    De Lisle RC; Mueller R; Boyd M
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):371-9. PubMed ID: 21970994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small intestinal glucose absorption in cystic fibrosis: a study in human and transgenic DeltaF508 cystic fibrosis mouse tissues.
    Hardcastle J; Harwood MD; Taylor CJ
    J Pharm Pharmacol; 2004 Mar; 56(3):329-38. PubMed ID: 15025858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
    Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model.
    Freudenberg F; Broderick AL; Yu BB; Leonard MR; Glickman JN; Carey MC
    Am J Physiol Gastrointest Liver Physiol; 2008 Jun; 294(6):G1411-20. PubMed ID: 18436622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.
    Freudenberg F; Leonard MR; Liu SA; Glickman JN; Carey MC
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G205-14. PubMed ID: 20430874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3.
    McHugh DR; Cotton CU; Moss FJ; Vitko M; Valerio DM; Kelley TJ; Hao S; Jafri A; Drumm ML; Boron WF; Stern RC; McBennett K; Hodges CA
    Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G868-G878. PubMed ID: 30118317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis.
    Gelzo M; Iacotucci P; Caputo M; Cernera G; Comegna M; Carnovale V; Corso G; Castaldo G
    J Cyst Fibros; 2021 Jan; 20(1):e1-e6. PubMed ID: 32586737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of nutrition on phenotype in CFTR-deficient mice.
    Cottart CH; Bonvin E; Rey C; Wendum D; Bernaudin JF; Dumont S; Lasnier E; Debray D; Clément A; Housset C; Bonora M
    Pediatr Res; 2007 Nov; 62(5):528-32. PubMed ID: 17805210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.
    Debray D; Rainteau D; Barbu V; Rouahi M; El Mourabit H; Lerondel S; Rey C; Humbert L; Wendum D; Cottart CH; Dawson P; Chignard N; Housset C
    Gastroenterology; 2012 Jun; 142(7):1581-91.e6. PubMed ID: 22370478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of taurocholic acid by the ileum of normal and transgenic DeltaF508 cystic fibrosis mice.
    Hardcastle J; Harwood MD; Taylor CJ
    J Pharm Pharmacol; 2004 Apr; 56(4):445-52. PubMed ID: 15099439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Expression of Enterocyte Nutrient Assimilation Genes and Proteins in the Small Intestine of Cystic Fibrosis Mouse.
    De Lisle RC
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):627-34. PubMed ID: 26551319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study.
    Amato F; Castaldo A; Castaldo G; Cernera G; Corso G; Ferrari E; Gelzo M; Monzani R; Villella VR; Raia V
    PLoS One; 2021; 16(1):e0245302. PubMed ID: 33412572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.